FDA approves J&J’s TECNIS PureSee intraocular lens
By Salong Debbarma
Published on March 13, 2026.
Johnson & Johnson (J&J) has received approval for its TECNIS PureSee extended depth of focus (EDOF) intraocular lens (IOL), designed for cataract surgery. The lens combines advanced optics with proprietary materials to extend focus and address presbyopia. It is said to be the first and only FDA-approved EDOF IOL in the US without a warning on loss of contrast sensitivity. The product is expected to become available for US patients later this year. The approval adds to J&J's surgical vision portfolio, which includes other lenses such as TECnIS Odyssey IOL and TECMIS Eyhance IOL.
Read Original Article